F.D.A. Staff Raises Concerns About Arthritis Drug
Tuesday, May 8, 2012 - 01:20
in Health & Medicine
As an advisory panel prepared to consider whether to recommend federal approval of Pfizer’s rheumatoid arthritis pill, F.D.A. documents raise safety questions.